Emergent BioSolutions Inc. (EBS) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$742.9M

Net Income/Loss (FY2025)

$52.6M

Total Assets (FY2025)

$1.3B

Total Equity (FY2025)

$522.6M

Cash Flows from Operating Activities (FY2025)

$170.6M

Source: Emergent BioSolutions Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.